D.L. Cheney

4.8k total citations
78 papers, 3.8k citations indexed

About

D.L. Cheney is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, D.L. Cheney has authored 78 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Cellular and Molecular Neuroscience, 32 papers in Molecular Biology and 11 papers in Physiology. Recurrent topics in D.L. Cheney's work include Neuroscience and Neuropharmacology Research (44 papers), Neurotransmitter Receptor Influence on Behavior (21 papers) and Receptor Mechanisms and Signaling (18 papers). D.L. Cheney is often cited by papers focused on Neuroscience and Neuropharmacology Research (44 papers), Neurotransmitter Receptor Influence on Behavior (21 papers) and Receptor Mechanisms and Signaling (18 papers). D.L. Cheney collaborates with scholars based in United States, Switzerland and Hungary. D.L. Cheney's co-authors include E. Costa, Giorgio Racagni, M. Trabucchi, Paul L. Wood, Flavio Moroni, G. Zsilla, Avram Goldstein, A. Revuelta, Pertti Panula and Hamidreza Ghandehari and has published in prestigious journals such as Nature, Science and Advanced Drug Delivery Reviews.

In The Last Decade

D.L. Cheney

78 papers receiving 3.6k citations

Peers

Countries citing papers authored by D.L. Cheney

Since Specialization

Citations

This map shows the geographic impact of D.L. Cheney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.L. Cheney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.L. Cheney more than expected).

Fields of papers citing papers by D.L. Cheney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.L. Cheney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.L. Cheney. The network helps show where D.L. Cheney may publish in the future.

Co-authorship network of co-authors of D.L. Cheney

This figure shows the co-authorship network connecting the top 25 collaborators of D.L. Cheney. A scholar is included among the top collaborators of D.L. Cheney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.L. Cheney. D.L. Cheney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Protein-based polymer liquid embolics for cerebral aneurysms 2022 ·Acta Biomaterialia ·Mark Martin Jensen, Øyvind Hatlevik, (unknown), (unknown), (unknown), Kyle J. Isaacson, (unknown), Eugene Huo, Philipp Taussky, Jolanta Jedrzkiewicz, Joseph Cappello, D.L. Cheney, Hamidreza Ghandehari	5
2	One-year chronic toxicity evaluation of single dose intravenously administered silica nanoparticles in mice and their Ex vivo human hemocompatibility 2020 ·Journal of Controlled Release ·Raziye Mohammadpour, D.L. Cheney, (unknown), Mostafa Yazdimamaghani, Jolanta Jedrzkiewicz, Kyle J. Isaacson, Marina A. Dobrovolskaia, Hamidreza Ghandehari	88
3	Subchronic and chronic toxicity evaluation of inorganic nanoparticles for delivery applications 2019 ·Advanced Drug Delivery Reviews ·Raziye Mohammadpour, Marina A. Dobrovolskaia, D.L. Cheney, Khaled Greish, Hamidreza Ghandehari	189
4	Biodegradable multiblock poly(N-2-hydroxypropyl)methacrylamide gemcitabine and paclitaxel conjugates for ovarian cancer cell combination treatment 2013 ·International Journal of Pharmaceutics ·Nate Larson, Jiyuan Yang, Abhijit Ray, D.L. Cheney, (unknown), Jindřich Kopeček	47
5	Mitochondrial diazepam-binding inhibitor receptor complex agonists antagonize dizocilpine amnesia: putative role for allopregnanolone. 1994 ·Journal of Pharmacology and Experimental Therapeutics ·Elena Romeo, D.L. Cheney, Irena Živković, E. Costa, A Guidotti	49
6	Constant infusion of [13C6]glucose: Simultaneous measurement of turnover of GABA and glutamate in defined regions of the brain of individual animals 1988 ·Neuropharmacology ·Patrick B. Wood, Hyungmin Kim, D.L. Cheney, Cristina Cosi, M. Marien, Tadimeti S. Rao, L. Martin	19
7	Antagonism of N-methyl-D-aspartate (NMDA) evoked increases in cerebellar cGMP and striatal ACh release by phencyclidine (PCP) receptor agonists; evidence for possible allosteric coupling of NMDA and PCP receptors 1987 ·Canadian Journal of Physiology and Pharmacology ·Paul L. Wood, Douglas J. Steel, (unknown), D.L. Cheney, John Lehmann	44
8	Simultaneous modulation of hippocampal cholinergic activity and extinction by intraseptal muscimol. 1983 ·Journal of Pharmacology and Experimental Therapeutics ·William D. Blaker, D.L. Cheney, Ottavio Gandolfi, E Costa	15
9	Inhibition of acetylcholine turnover rate in rat hippocampus and cortex by intraventricular injection of adenosine analogs. 1982 ·Journal of Pharmacology and Experimental Therapeutics ·Thomas F. Murray, William D. Blaker, D.L. Cheney, Elı́sio Costa	29
10	The septal-hippocampal cholinergic pathway: role in antagonism of pentobarbital anesthesia and regulation by various afferents. 1981 ·Journal of Pharmacology and Experimental Therapeutics ·N. Brunello, D.L. Cheney	47
11	The effect of phencyclidine on the turnover rate of acetylcholine in various regions of rat brain. 1981 ·Journal of Pharmacology and Experimental Therapeutics ·Thomas F. Murray, D.L. Cheney	11
12	Reduction of hippocampal acetylcholine turnover in rats treated with (−)-Δ8-tetrahydrocannabinol and its 1′,2′-dimethyl-heptyl homolog 1980 ·Brain Research ·A. Revuelta, D.L. Cheney, E. Costa, N. Lander, Raphael Mechoulam	17
13	On the regulation of gamma-aminobutyric acid neurons in caudatus, pallidus and nigra: effects of opioids and dopamine agonists. 1979 ·Journal of Pharmacology and Experimental Therapeutics ·Flavio Moroni, E. Peralta, D.L. Cheney, E. Costa	41
14	Modulation of acetylcholine metabolism in the hippocampal cholinergic pathway by intraseptally injected substance P. 1978 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown), D.L. Cheney, Eduardo Costa	30
15	In vivo actions of clozapine and haloperidol on the turnover rate of acetylcholine in rat striatum. 1976 ·Journal of Pharmacology and Experimental Therapeutics ·Giorgio Racagni, D.L. Cheney, M. Trabucchi, Eduardo Damasceno Costa	67
16	Regional changes in the rate of turnover of acetylcholine in rat brain following diazepam or muscimol 1976 ·Naunyn-Schmiedeberg s Archives of Pharmacology ·G. Zsilla, D.L. Cheney, E. Costa	63
17	Application of principles of steady-state kinetics to the in vivo estimation of acetylcholine turnover rate in mouse brain. 1975 ·Journal of Pharmacology and Experimental Therapeutics ·D.L. Cheney, E. Costa, Israel Hanin, M. Trabucchi, (unknown)	22
18	Morphine dependence and in vivo turnover of acetylcholine in whole mouse brain. 1975 ·Journal of Pharmacology and Experimental Therapeutics ·D.L. Cheney, M. Trabucchi, Israel Hanin, Elı́sio Costa	11
19	Application of principles of steady-state kinetics to the estimation of brain acetylcholine turnover rate: effects of oxotremorine and physostigmine. 1975 ·Journal of Pharmacology and Experimental Therapeutics ·M. Trabucchi, D.L. Cheney, Israel Hanin, Elı́sio Costa	39
20	Focussed microwave radiation: a technique to minimize post mortem changes of cyclic nucleotides, dopa and choline and to preserve brain morphology 1974 ·Neuropharmacology ·Alessandro Guidotti, D.L. Cheney, Marco Trabucchi, Masami Doteuchi, (unknown), Richard A. Hawkins	268

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact